TROPICAMIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for tropicamide and what is the scope of patent protection?
Tropicamide
is the generic ingredient in four branded drugs marketed by Alcon, Alcon Labs Inc, Sandoz, Pharmafair, Epic Pharma Llc, Rising, Alcon Pharms Ltd, Bausch And Lomb, Miza Pharms Usa, Somerset Theraps Llc, and Watson Labs, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.There are seven drug master file entries for tropicamide. Four suppliers are listed for this compound.
Summary for TROPICAMIDE
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 11 |
NDAs: | 15 |
Drug Master File Entries: | 7 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 110 |
Clinical Trials: | 41 |
Patent Applications: | 6,553 |
Drug Prices: | Drug price trends for TROPICAMIDE |
What excipients (inactive ingredients) are in TROPICAMIDE? | TROPICAMIDE excipients list |
DailyMed Link: | TROPICAMIDE at DailyMed |
Recent Clinical Trials for TROPICAMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yarmouk University | Phase 4 |
Jordan University of Science and Technology | Phase 4 |
Shanghai Eye Disease Prevention and Treatment Center | Phase 4 |
Pharmacology for TROPICAMIDE
Drug Class | Anticholinergic |
Mechanism of Action | Cholinergic Antagonists |
Medical Subject Heading (MeSH) Categories for TROPICAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for TROPICAMIDE
US Patents and Regulatory Information for TROPICAMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Miza Pharms Usa | TROPICAMIDE | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 087636-001 | Jul 30, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Miza Pharms Usa | TROPICAMIDE | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 087637-001 | Aug 9, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Epic Pharma Llc | TROPICACYL | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 040314-001 | Sep 29, 2000 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Alcon | MYDRIACYL | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 012111-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Somerset Theraps Llc | TROPICAMIDE | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 207524-001 | Dec 12, 2019 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Bausch And Lomb | TROPICAMIDE | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 040064-001 | Jul 27, 1994 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.